Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.
作者信息
Hamblin Peter S, Wong Rosemary, Bach Leon A
机构信息
Western Health, Melbourne, VIC.
University of Melbourne, Melbourne, VIC.
出版信息
Med J Aust. 2021 Feb;214(2):94-94.e1. doi: 10.5694/mja2.50898. Epub 2020 Dec 21.
PMID:33349919
Abstract
摘要
相似文献
1
Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.2型钠-葡萄糖协同转运蛋白抑制剂：应对糖尿病酮症酸中毒这一虽小但关键的风险
Med J Aust. 2021 Feb;214(2):94-94.e1. doi: 10.5694/mja2.50898. Epub 2020 Dec 21.
2
Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.2型钠-葡萄糖协同转运蛋白抑制剂：应对糖尿病酮症酸中毒这一虽小但关键的风险
Med J Aust. 2021 Feb;214(2):93-93.e1. doi: 10.5694/mja2.50899. Epub 2020 Dec 21.
3
In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.在 2 型糖尿病中，SGLT2 抑制剂与 DPP-4 抑制剂相比与糖尿病酮症酸中毒相关。
Ann Intern Med. 2020 Dec 15;173(12):JC70. doi: 10.7326/ACPJ202012150-070.
4
Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.2型钠-葡萄糖协同转运蛋白抑制剂：应对糖尿病酮症酸中毒这一虽小但关键的风险
Med J Aust. 2020 Apr;212(7):294-296.e1. doi: 10.5694/mja2.50525. Epub 2020 Mar 3.
5
Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.恩格列净所致酮症酸中毒：一种范式转变——病例报告及文献综述
Curr Diabetes Rev. 2019;15(4):259-262. doi: 10.2174/1573399814666180726114044.
6
Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor.使用钠-葡萄糖协同转运蛋白2抑制剂治疗的2型糖尿病患者中的正常血糖性糖尿病酮症酸中毒
Can Fam Physician. 2016 Sep;62(9):722-4.
7
Sodium glucose cotransporter 2 inhibitor-induced ketoacidosis is unlikely in patients without diabetes.在无糖尿病的患者中，钠-葡萄糖协同转运蛋白2抑制剂诱发酮症酸中毒的可能性不大。
Med J Aust. 2023 Oct 2;219(7):293-294. doi: 10.5694/mja2.52067. Epub 2023 Aug 7.
8
SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes.钠-葡萄糖协同转运蛋白 2（SGLT2）抑制剂会增加 2 型糖尿病患者发生糖尿病酮症酸中毒的风险。
Ann Intern Med. 2020 Oct 20;173(8):JC40. doi: 10.7326/ACPJ202010200-040.
9
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter type 2 inhibitors.与2型钠-葡萄糖协同转运蛋白抑制剂相关的正常血糖性糖尿病酮症酸中毒
Med Clin (Barc). 2024 Jul 26;163(2):101-102. doi: 10.1016/j.medcli.2024.01.025. Epub 2024 Apr 26.
10
Diabetic ketoacidosis with sodium-glucose cotransporter type 2 inhibitors: a case series.2型钠-葡萄糖协同转运蛋白抑制剂所致糖尿病酮症酸中毒：病例系列
Med J Aust. 2019 Sep;211(5):237-237.e1. doi: 10.5694/mja2.50302. Epub 2019 Aug 16.
引用本文的文献
1
Sodium glucose co-transporter 2 inhibitor-associated euglycaemic diabetic ketoacidosis in the emergency peri-operative period: a systematic review.围手术期急诊中钠-葡萄糖协同转运蛋白2抑制剂相关的正常血糖性糖尿病酮症酸中毒：一项系统评价
J Anesth. 2025 Aug 31. doi: 10.1007/s00540-025-03570-2.
Zotero 插件